Rheumatology: Current Research
Open Access

Tomoya Miyamura

Publications

• Case Report
  Risk of Lymphoproliferative Disorders in Spondyloarthritis during Treatment with Methotrexate: A Case Report and Literature Review
  Author(s): Akihiro Nakamura, Tomoya Miyamura, Brian Wub and Eiichi Suematsu Akihiro Nakamura, Tomoya Miyamura, Brian Wub and Eiichi Suematsu
  
  Unlike rheumatoid arthritis, risks of lymphoproliferative disorders (LPDs) in spondyloarthritis (SpA) are not well established. Recent studies suggest that the overall risk of lymphoma does not seem to be increased compared to the general population, however, SpA patients taking disease-modifying anti-rheumatic drugs including methotrexate (MTX) may link to higher occurrence of LPDs. We herein report a 40-year-old man diagnosed with non-radiographic axial SpA according to the Assessment of Spondyloarthritis International Society (ASAS) classification criteria. While initiation of oral MTX and celecoxib treatments appeared to gradually improve symptoms, cervical lymphadenopathy appeared accompanied by fever and deteriorated arthritis following 13 months. Laboratory results showed increased serum levels of inflammatory markers, liver transaminases, soluble interleukin-2 receptor and fer.. View More»
  DOI: 10.4172/2161-1149.1000186

  Abstract PDF

Relevant Topics